FierceBiotech and its family of publications provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way. We track tiny, virtual startups and the biggest of Big Pharma, highlighting the accomplishments and acknowledging the defeats that all of them experience on their way to market with a new therapy or device. The FierceBiotech team transcends the daily as well, with comprehensive coverage of key medical meetings plus special reports that highlight up-and-comers and shed new light on industry heavyweights.
Every business day, FiercePharma updates pharmaceutical executives on company news and earnings, FDA regulations, drug safety, generic drug companies, and more. Beyond the news of the day, our editors produce in-depth features on industry leaders and market trends. As a member of our community, you will receive an exclusive invitation to each of our webinars and gain full access to our entire white paper and eBook library. Advance your career by attending our networking parties and taking full advantage of our job board. Visit our website and start receiving our free FiercePharma email newsletter!
PM360 is the premier, must-read magazine for marketing decision-makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Serving nearly 6 million senior executives, thought leaders and industry professionals, SmartBrief is the leading digital media publisher of targeted business news and information by industry. By combining technology and editorial expertise, SmartBrief filters thousands of sources daily to deliver the most relevant industry news in partnership with leading trade associations, professional societies, nonprofits and corporate entities.
MEDtube is an online video-centric education and communication platform for healthcare professionals. It is now the world’s largest online repository with high-quality multimedia content of clear practical and educational value, counting +20,000 professional medical materials. The resources are shared by physicians, clinicists, medical societies and universities. The community counts +150,000 registered professional users who contribute to the idea of sharing medical knowledge.
The founders of CanBiotech from institutions including M.I.T, Harvard, Brown, McGill, University of Waterloo and University of Toronto, aim to create a central hub for the bio-medical industry through its portals and marketplaces, with equal, yet distinct representation of each of the bio-medical sectors: therapeutics/biopharmaceuticals, agrifood, devices/diagnostics.
The founders of CanBiotech bring over 13 years of experience in molecular biology, cancer biology, gene therapy, drug delivery, bio-IT, biopharmaceutical business development, software and web development from various arenas including the biopharmaceutical industry, the agbiotech industry, the financial industry and the public sector.
CanBiotech, a private venture, is a company whose central premise is forming partnerships and creating synergies with a focus on the outsourcing of biomedical research and business services through CanBiotech's online marketplaces or through CanBiotech's physical arm: CanBiotech Consulting. The goal is to enhance the biomedical industry, enabling a new process of discovery and development, with an equal opportunity provided to all players, by fostering both cross-border interactivity between Canadian and U.S. biomedical companies as well as provide for international partnering opportunities for the biomedical industry.